Stephen Ashford

Further involvements

• 16/12/2022

  12:20 – 12:30 10 Min.

  • Oral Presentation
  • OP 080

  The impact of tracheostomy weaning on outcome and care costs in patient with prolonged disorders for consciousness (PDOC)

   Disorders of consciousness, Outcome measurement
• 16/12/2022

  13:35 – 13:40 5 Min.

  • ePoster Presentation
  • P 496

  Leg Activity Measure (LegA) sensitivity to change following treatment of lower limb spasticity with a single cycle of abobotulinumtoxinA in an ambulant population

   Outcome measurement, Spasticity
• 16/12/2022

  13:45 – 13:50 5 Min.

  • ePoster Presentation
  • P 313

  The impact of spasticity and contractures on dependency and outcomes from rehabilitation

   Stroke, Traumatic brain injury
• 16/12/2022

  15:30 – 15:35 5 Min.

  • ePoster Presentation
  • P 097

  Which are the most frequently injected muscles in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in routine practice? Baseline data from the AboLiSh study

   Motor neurorehabilitation, Spasticity
• 17/12/2022

  12:09 – 12:18 9 Min.

  • Oral Presentation
  • OP 112

  A 10-year Cohort analysis of tracheostomised patients with profound brain injury presenting to a UK tertiary specialist rehabilitation unit, 2010-2020

   Disorders of consciousness, Early neurorehabilitation